產品詳情
簡單介紹：
Anti-PPIL3/Cyclophilin J抗體產品質量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-PPIL3/Cyclophilin J抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-PPIL3/Cyclophilin J
Cat. Number:
Anti-PPIL3/Cyclophilin J抗體KL-21060R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the cyclophilin family. Cyclophilins catalyze the cis-trans isomerization of peptidylprolyl imideAnti-PPIL3/Cyclophilin J抗體 bonds in oligopeptides. They have been proposed to act either as catalysts or as molecular chaperones in protein-folding events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2008]
Also known as:
2310076N22Rik; 2510026K04Rik; Ccyclophilin like protein; Cyclophilin J; Cyclophilin like 3; Cyclophilin like protein 3; Cyclophilin like protein PPIL3; Cyclophilin-like protein PPIL3; Cyp10l; CyPJ; MGC105285; Peptidyl prolyl Anti-PPIL3/Cyclophilin J抗體cis trans isomerase like 3; Peptidyl-prolyl cis-trans isomerase-like 3; Peptidylprolyl cis trans isomerase like protein 3; Peptidylprolyl isomerase (cyclophilin) like 3; Peptidylprolyl isomerase like 3; PPIase; PPIase like protein 3; Ppil3; PPIL3_HUMAN; Rotamase; Rotamase PPIL3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated syntheticAnti-PPIL3/Cyclophilin J抗體 peptide derived from human PPIL3/Cyclophilin J.
●
Predicted Molecular Weight: 18kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-PPIL3/Cyclophilin J抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-PPIL3/Cyclophilin J抗體
Optimal working dilutions must be determined by the end user.
